Boudreau Philip P
- SEC CIK
- 0001805099
In the past year, 1 open-market purchase filing worth $201.3K and no sales.
Current role at each company
- ABT Abbott LaboratoriesEVP AND CFOas of Sep 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $201.3K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$201.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Boudreau Philip P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 (view filing) | Apr 23 | 4 days | Boudreau Philip PEVP AND CFO | PPurchaseCommon shares without par value | +2.20K | $91.50 | +$201.3K | New position2.20K after | |
| Aug 11, 2025 (view filing) | Aug 8 | 3 days | Boudreau Philip PEVP AND CFO | SSaleCommon shares without par value | −5.55K | $134.55 | −$746.8K | −9.8%51.0K after | |
| Jun 20, 2023 (view filing) | Jun 16 | 4 days | Boudreau Philip PVICE PRESIDENT | SSaleCommon shares without par value | −8.00K | $106.00 | −$848.0K | −34.1%15.4K after | 10b5-1 |
| Oct 27, 2021 (view filing) | Oct 25 | 2 days | Boudreau Philip PVICE PRESIDENT | SSaleCommon shares without par value | −8.00K | $126.49 | −$1.01M | −32.2%16.9K after |